231 Results for "

mutated TrkC

" in MedChemExpress (MCE) Product Catalog:
Products (231)

231 Results for "mutated TrkC" in MCE Product Catalog:

Cat. No.: HY-122631
CAS No.: 885272-55-9
Purity:  99.95%
Target:  

CDK Dystrophin

Research Areas:  

Others

TG693 is an orally active inhibitor of CLK1. TG693 regulates the mutated exon 31 of the dystrophin gene in vivo. TG693 is used in Duchenne muscular dystrophy (DMD) research .
loading...
    loading...
Cat. No.: HY-104067
CAS No.: 1596-56-1
Purity:  99.50%
Synonyms: NASTRp
Research Areas:  

Cancer

Naphthol AS-MX phosphate (NASTRp) is a small molecule inhibitor of the CREB (cyclic adenosine phosphate reaction element binding protein)-CBP (CREB binding protein) transcription factor complex. Naphthol AS-MX phosphate shows antitumor activity against lung cancer cells, inhibiting tumor cell proliferation (IC50=3.701 μmol/L), colony formation, and anchored independent growth in soft AGAR. Naphthol AS-MX phosphate can be used in the study of KRAS mutated lung cancer, especially for KRAS mutated lung cancer with poor chemotherapy resistance and prognosis .
loading...
    loading...
Cat. No.: HY-161235
Target:  

SOS1 Molecular Glues Ras

Research Areas:  

Cancer

BTX-7312 is a cereblon-based SOS1 bifunctional degrader and a molecular glue. BTX-7312 reduces downstream signaling markers pERK and pS6 and shows antiproliferative activity in various KRAS-mutated cells .
loading...
    loading...
Cat. No.: HY-19897
CAS No.: 895533-09-2
Target:  

FLT3 VEGFR

Research Areas:  

Cancer

4SC-203 is a potent multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively FLT3/STK1, FLT3 mutated forms, and VEGFRs .
loading...
    loading...
Cat. No.: HY-112437
CAS No.: 1863905-38-7
Purity:  99.70%
Target:  

Trk Receptor

Research Areas:  

Neurological Disease

PF-06737007 is a potent pan-Trk inhibitor in cell-based assays with IC50s of 7.7 nM, 15 nM and 3.9 nM for TrkA, TrkB and TrkC, respectively . Anti-hyperalgesic effect .
loading...
    loading...
Cat. No.: HY-132593
CAS No.: 2072901-32-5
Synonyms: WVE-120101
Target:  

Huntingtin

Research Areas:  

Neurological Disease

Rovanersen (WVE-120101) is an antisense oligonucleotide that specifically targets mutated mRNA copies of the huntington (HTT) gene without affecting healthy mRNA of HTT gene, thereby preventing the production of faulty Huntingtin protein. Rovanersen can be used for huntington’s disease research .
loading...
    loading...
Cat. No.: HY-19704
CAS No.: 1233363-33-1
Synonyms: CT327; SNA-120
Target:  

Trk Receptor

Research Areas:  

Inflammation/Immunology Cancer

Pegcantratinib (CT327) is a potent and selective TRKA antagonist with activity against TRKB and TRKC. Pegcantratinib can be used for research of CYLD cutaneous syndrome (CCS) and inflammatory dermatoses, such as psoriasis and concomitant pruritus .
loading...
    loading...
Cat. No.: HY-179219S
CAS No.: 3035072-99-9
RTx-303 is an orally active, selective DNA polymerase θ (Polθ) inhibitor (IC50 = 5.1 nM). RTx-303 exhibits significantly high cellular potency and strongly potentiates PARPi in BRCA1/2 mutant cells and patient-derived xenograft models. RTx-303 can be used for the study of BRCA2-mutated breast cancer .
loading...
    loading...
Cat. No.: HY-123307
CAS No.: 76578-12-6
Purity:  98.03%
Synonyms: Xylafop
Research Areas:  

Others

Quizalofop (Xylafop) is a herbicide that inhibits acetyl-CoA carboxylase (ACCase) to reduce the synthesis of fatty acids. Quizalofop can be used to screen EMS (HY-W015854) mutated microalgae for research on improving the performance of microalgae biofuel production .
loading...
    loading...
Cat. No.: HY-164466
CAS No.: 2682205-20-3
Target:  

Calcium Channel Notch

Research Areas:  

Cancer

CAD204520, a SERCA inhibitor (IC50 = 0.34 μM), targets mutated over wild type NOTCH1 proteins in T-cell acute lymphoblastic leukemia (T-ALL) and mantle cell lymphoma (MCL). CAD204520 can be used for T-ALL and MCL research .
loading...
    loading...
Cat. No.: HY-175274
CAS No.: 304480-98-6
Target:  

FLT3

Research Areas:  

Cancer

MolPort-002-705-878 is a highly selective FMS-like tyrosine kinase 3 (FLT3) inhibitor with a binding affinity of −11.33 kcal/mol. MolPort-002-705-878 inhibits the proliferation of FLT3-mutated acute myeloid leukemia (AML) cells. MolPort-002-705-878 is promising for research of FLT3-mutated AML .
loading...
    loading...
Cat. No.: HY-134481
CAS No.: 2088735-51-5
Purity:  98.80%
Target:  

FLT3

Research Areas:  

Cancer

FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 has the potential for the research of FLT3-mutated acute myeloid leukemia (AML) .
loading...
    loading...
Cat. No.: HY-162440
Target:  

Ras

Research Areas:  

Cancer

pan-KRAS-IN-7 (Compound 25) is an inhibitor for in human tumor mutated genes KRAS, which inhibits proliferation of KRAS mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC50 of 0.35 and 0.51 nM, respectively .
loading...
    loading...
Cat. No.: HY-162443
Target:  

Ras

Research Areas:  

Cancer

pan-KRAS-IN-10 (Compound 58) is an inhibitor for in human tumor mutated genes KRAS, which inhibits proliferation of KRAS mutated cells AsPC-1 (G12D mutant) and SW480 (G12V mutant) with IC50 of 0.7 and 0.24 nM, respectively .
loading...
    loading...
Cat. No.: HY-10638
CAS No.: 845895-51-4
Target:  

c-Kit Apoptosis

Research Areas:  

Cancer

AP23464 is an ATP-based inhibitor for Kit, that inhibits the phosphorylation of Kit wildtype and mutants, with IC50 of 5-85 nM. AP23464 inhibits the proliferation of Kit mutated cells (IC50 is 3-20 nM), arrests the cell cycle at G0/G1 phase, and induces apoptosis in Kit mutated cells .
loading...
    loading...
Cat. No.: HY-144214
CAS No.: 2713577-93-4
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-10 is a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase with an IC50 value of 2.978 μM.
loading...
    loading...
Cat. No.: HY-147580
CAS No.: 2758596-07-3
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-10 is a potent BTK inhibitor with IC50s of <5 nM for wild-type BTK or mutated BTK (C481S), respectively (WO2022012509A1; example 111) .
loading...
    loading...
Cat. No.: HY-178996
Research Areas:  

Cancer

FLT3-IN-36 is a potent FLT3 inhibitor. FLT3-IN-36 exhibits antitumor activity against FLT3-mutated acute myeloid leukemia (AML) cells. FLT3-IN-36 induces cell cycle arrest, reduces mitochondrial membrane potential, and induces apoptosis, downregulating FLT3 and downstream protein expression (including AKT, ERK, PI3K, and STAT5). FLT3-IN-36 can be used for AML research .
loading...
    loading...
Cat. No.: HY-177081
CAS No.: 2952542-22-0
Target:  

MEK

Research Areas:  

Cancer

Envometinib (Compound B) is a dual-MEK inhibitor that works through Deep Cyclic Inhibition (DCI). Envometinib has antitumor activity in various in vivo models. Envometinib can be studied in RAS and RAF mutated cancer such as colorectal cancer and melanoma .
loading...
    loading...
Cat. No.: HY-132593A
CAS No.: 2231347-41-2
Purity:  95.58%
Synonyms: WVE-120101 sodium
Target:  

Huntingtin

Research Areas:  

Neurological Disease

Rovanersen sodium is an antisense oligonucleotide that specifically targets mutated mRNA copies of the huntington (HTT) gene without affecting healthy mRNA of HTT gene, thereby preventing the production of faulty Huntingtin protein. Rovanersen sodium can be used for huntington’s disease research .
loading...
    loading...